125 related articles for article (PubMed ID: 9704178)
1. A phase II trial of four courses of preoperative chemotherapy in squamous or anaplastic carcinoma of the oesophagus.
Steyn RS; Darnton SJ; McManus KG; McAleer JA; Cullen MH; Matthews HR
Clin Oncol (R Coll Radiol); 1998; 10(3):165-9. PubMed ID: 9704178
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus.
Allen SM; Duffy JP; Walker SJ; Darnton SJ; Cullen MH; Matthews HR
Clin Oncol (R Coll Radiol); 1994; 6(2):91-5. PubMed ID: 8018579
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus.
Darnton SJ; Ferry DR; Cullen MH; Casson AG
Clin Oncol (R Coll Radiol); 1998; 10(6):372-6. PubMed ID: 9890538
[TBL] [Abstract][Full Text] [Related]
4. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
Darnton SJ; Archer VR; Stocken DD; Mulholland PJ; Casson AG; Ferry DR
J Clin Oncol; 2003 Nov; 21(21):4009-15. PubMed ID: 14581424
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
Allen SM; Duffy JP; Darnton SJ; Cullen MH; Matthews HR
Cancer Chemother Pharmacol; 1996; 37(5):496-8. PubMed ID: 8599875
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus.
Steyn RS; Vijeyasingam R; Darnton SJ; Cullen MH; Matthews HR
Clin Oncol (R Coll Radiol); 1998; 10(3):170-2. PubMed ID: 9704179
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Soh LT; Tan EH; Ang PT
Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma.
Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M
Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.
Urban T; Bedin A; Baud M; Chouaid C; Febvre M; Lebeau B
Lung Cancer; 1996 Feb; 14(1):109-17. PubMed ID: 8696714
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Currie DC; Miles DW; Drake JS; Rudd R; Spiro SG; Earl HM; Harper PG; Tobias JS; Souhami RL
Cancer Chemother Pharmacol; 1990; 25(5):380-1. PubMed ID: 2155066
[TBL] [Abstract][Full Text] [Related]
14. Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma.
Cocconi G; Bella M; Lottici R; Leonardi F; Ceci G; Passalacqua R; Di Blasio B; Bordi C; Biscottini B; Melpignano M; De Biasi D; Finardi C; Bacchi M
Am J Clin Oncol; 1999 Dec; 22(6):559-67. PubMed ID: 10597739
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
[TBL] [Abstract][Full Text] [Related]
16. Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
Delaloye JF; Leyvraz S; Outcha Adjahoto E; Bauer J; De Grandi P
Am J Clin Oncol; 1996 Apr; 19(2):204-6. PubMed ID: 8610651
[TBL] [Abstract][Full Text] [Related]
17. Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
Darnton SJ; Allen SM; Edwards CW; Matthews HR
J Clin Pathol; 1993 Jan; 46(1):51-5. PubMed ID: 8432889
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
